ARTICLE | Company News
Pfizer, Astellas deal
September 15, 2014 7:00 AM UTC
The pharmas agreed to terminate on March 31, 2015, a 2009 deal to co-commercialize Caduet amlodipine besylate/atorvastatin for hypertension and hypercholesterolemia in Japan. Pfizer will be responsib...